BRISTOL MYERS SQUIBB

🇫🇷France
Ownership
-
Established
1989-01-01
Employees
30K
Market Cap
$97.5B
Website
https://www.bms.com/

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Phase 2
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2011-05-04
Lead Sponsor
Bristol-Myers Squibb
Registration Number
NCT00004584
Locations
🇺🇸

HIV Clinical Research, Fort Lauderdale, Florida, United States

🇺🇸

Infectious Disease Specialists of Atlanta, Decatur, Georgia, United States

🇺🇸

Albany Med College, Albany, New York, United States

and more 35 locations
© Copyright 2024. All Rights Reserved by MedPath